Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eiichi Tahara is active.

Publication


Featured researches published by Eiichi Tahara.


Journal of Ethnopharmacology | 1999

Effect of Shimotsu-to (a Kampo medicine, Si-Wu-Tang) and its constituents on triphasic skin reaction in passively sensitized mice.

Eiichi Tahara; Taku Satoh; Kazuo Toriizuka; Hiroichi Nagai; Shinyu Nunome; Yutaka Shimada; Takashi Itoh; Katsutoshi Terasawa; Ikuo Saiki

Previous studies have reported that mice passively sensitized with anti-DNP (dinitrophenol) IgE antibody exhibited IgE-mediated skin reaction with an immediate phase response (IPR) at 1 h and a late phase response (LPR) at 24 h after the challenge of DNFB (dinitrofluorobenzene). We recently found that a third phase inflammatory reaction with intense and persisting infiltration of eosinophils, named very late phase response (vLPR), was induced by DNFB challenge peaking at 8 days. In this study, we examined the effects of a Kampo medicine, Shimotsu-to (Si-Wu-Tang), and its constituent crude drugs on triphasic skin reaction in passively sensitized mice. Shimotsu-to inhibited ear swelling in LPR and vLPR after DNFB challenge in a dose-dependent manner, and slightly diminished the scratching behavior considered to be associated with pruritus in IPR. The inhibitory effect on LPR and vLPR was partly due to Cnidii Rhizoma (Senkyu) in Shimotsu-to formulation, especially its fraction 5 containing cnidilide. On the other hand, Angelicae Radix (Toki) rather than Cnidii Rhizoma (Senkyu) in Shimotsu-to, inhibited the scratching behavior, although it did not inhibit the ear swelling in IPR. These findings indicate that the Shimotsu-to formulation is useful for the inhibition of cutaneous inflammatory diseases.


Pharmacology | 2000

Differential Effect of Antiallergic Drugs on IgE-Mediated Cutaneous Reaction in Passively Sensitized Mice

Taku Satoh; Eiichi Tahara; Tomohiro Yamada; Chie Watanabe; Takashi Itoh; Katsutoshi Terasawa; Hiroichi Nagai; Ikuo Saiki

We investigated the effect of several antiallergic agents on murine IgE-mediated biphasic cutaneous reaction. Mice were passively sensitized by an intravenous injection of monoclonal anti-dinitrophenol (anti-DNP) IgE antibody. Skin reaction was elicited by an epicutaneous challenge of dinitrofluorobenzene (DNFB) and occurred biphasically with immediate-phase response (IPR) and late-phase response (LPR) at 1 and 24 h, respectively. Classical histamine H1 receptor antagonists and some chemical mediator-release inhibitors, such as diphenhydramine and terfenadine, inhibited IPR, but not LPR. In contrast, leukotriene B4 (LTB4) receptor antagonist (ONO-4057) inhibited LPR only. Antagonists for LTC4, D4, E4 receptor (ONO-1078) and platelet-activating factor (PAF) receptor (Y-24180) significantly inhibited both IPR and LPR, similarly to prednisolone. We recently found that a third-phase inflammatory reaction with marked infiltration of eosinophils (named very-late-phase response; vLPR), which is supposed to be a more important reaction in allergic diseases, was induced, peaking at day 8 following IPR and LPR in this model. The effect of these drugs on the triphasic skin reaction can be scored based on efficacy against IPR / LPR / vLPR; +/+/+ (prednisolone, a PAF receptor antagonist Y-24180, cyclosporin A and FK-506), +/–/– (diphenhydramine), +/+/– (azelastine and LT receptor antagonist ONO-1078), and –/+/+ (an LTB4 receptor antagonist ONO-4057). Thus the inhibitory effect on vLPR as well as LPR may relate to the inhibition of eosinophil function mediated by LTB4 and PAF and/or T cells. These findings may provide the basis for a treatment modality using various antiallergic agents in allergic disease.


Geriatrics & Gerontology International | 2004

Assessment of effects of traditional herbal medicines on elderly patients with weakness using a self‐controlled trial

Toshiaki Kogure; Nobuhiko Sato; Eiichi Tahara; Shinya Sakai; Yutaka Shimada; Hiroshi Ochiai; Hideki Origasa; Katsutoshi Terasawa

Background:  The objectives of this study were to evaluate the effects of traditional herbal medicine on elderly patients with weakness, and to devise a suitable study design for assessing the clinical effectiveness of traditional herbal medicines.


Kampo Medicine | 2014

A Case of Granuloma Annulare Successfully Treated with a Combination of Orengedokuto and Maobushisaishinto

Shizuka Ota; Hiromi Maeda; Yui Ito; Koso Ueda; Akihito Yoshimura; Junichiro Dokura; Jun Iwanaga; Hiromi Yano; Hisashi Inuzuka; Eiichi Tahara

受付:2013年6月3日,受理:2013年8月16日 Abstract A 68-year-old female had been diagnosed with granuloma annulare a year earlier. She was prescribed tranilast and was recovering, but had to discontinue the tranilast because she suffered liver damage as a side effect. She was also suffering from a worsening rash and so decided to try Kampo medicine. We prescribed orengedokuto because of thermal symptoms suggestive of hot flushes, the appearance of her tongue, and the character of her rash. Initially, the rash improved, but from the 3rd day following admission did not change greatly. We suspected the existence of interior cold and started combining maobushisaishinto. Five days later, the granulomas had rapidly shrunk. We believe she had overlapping diseases of a yin and yang pattern from the fact that she improved clinically.


Phytomedicine | 2004

Protective effect of Keishi-bukuryo-gan and its constituent medicinal plants against nitric oxide donor-induced neuronal death in cultured cerebellar granule cells

Yutaka Shimada; Koichi Yokoyama; Hirozo Goto; Nobuyasu Sekiya; Naoki Mantani; Eiichi Tahara; Hiroaki Hikiami; Katsutoshi Terasawa


Phytomedicine | 2005

A randomized double blind placebo-controlled clinical trial of Hochuekkito, a traditional herbal medicine, in the treatment of elderly patients with weakness N of one and responder restricted design

N. Satoh; Shinya Sakai; Toshiaki Kogure; Eiichi Tahara; Hideki Origasa; Yutaka Shimada; K. Kohoda; T. Okubo; Katsutoshi Terasawa


Biological & Pharmaceutical Bulletin | 1999

Inhibitory Mechanisms of Glycoprotein Fraction Derived from Miscanthus sinensis for the Immediate Phase Response of an IgE-Mediated Cutaneous Reaction

Chie Watanabe; Taku Satoh; Eiichi Tahara; Koji Murakami; Kazuko Hayashi; Koji Hase; Tsugunobu Andoh; Yasushi Kuraishi; Shigetoshi Kadota; Hiroichi Nagai; Ikuo Saiki


Allergology International | 1999

A third-phase cutaneous (very late phase) response after elicitation with dinitrofluorobenzene in passively or actively sensitized mice

Eiichi Tahara; Taku Satoh; Chie Watanabe; Yutaka Shimada; Takashi Itoh; Hiroichi Nagai; Katsutoshi Terasawa; Ikuo Saiki


Journal of Alternative and Complementary Medicine | 2005

Reduction of perception of chronic fatigue in an observational study of patients receiving 12 weeks of Kampo therapy.

Nobuyasu Sekiya; Yutaka Shimada; Takahiro Shintani; Eiichi Tahara; Naotoshi Shibahara; Katsutoshi Terasawa


和漢医薬学雑誌 = Journal of traditional medicines | 1997

Effect of Kampo treatment on chronic viral hepatitis on the basis of traditional diagnosis

Takashi Itoh; Naotoshi Shibahara; Naoki Mantani; Eiichi Tahara; Yutaka Shimada; Katsutoshi Terasawa

Collaboration


Dive into the Eiichi Tahara's collaboration.

Top Co-Authors

Avatar

Tadamichi Mitsuma

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroichi Nagai

Gifu Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge